ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 97 filers reported holding ONCOCYTE CORP in Q3 2021. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $99,000 | -18.2% | 135,000 | 0.0% | 0.03% | -15.4% |
Q2 2022 | $121,000 | -39.8% | 135,000 | 0.0% | 0.04% | -33.9% |
Q1 2022 | $201,000 | -31.4% | 135,000 | 0.0% | 0.06% | -30.6% |
Q4 2021 | $293,000 | -25.3% | 135,000 | +22.7% | 0.08% | -33.6% |
Q3 2021 | $392,000 | -37.4% | 110,000 | +0.9% | 0.13% | -38.8% |
Q2 2021 | $626,000 | +17.0% | 109,000 | +5.8% | 0.21% | -1.4% |
Q1 2021 | $535,000 | – | 103,000 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 23,353,697 | $17,048,000 | 1.30% |
AWM Investment Company, Inc. | 7,746,557 | $5,655,000 | 0.86% |
PURA VIDA INVESTMENTS, LLC | 18,056,274 | $13,181,000 | 0.76% |
Defender Capital, LLC. | 2,551,980 | $1,883,000 | 0.74% |
Penbrook Management LLC | 563,350 | $411,000 | 0.35% |
ACT CAPITAL MANAGEMENT, LLC | 330,000 | $241,000 | 0.33% |
CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $55,000 | 0.04% |
Fort Sheridan Advisors LLC | 135,000 | $99,000 | 0.03% |
Orbimed Advisors | 1,882,768 | $1,374,000 | 0.03% |
WEALTH EFFECTS LLC | 51,000 | $37,000 | 0.02% |